<DOC>
	<DOCNO>NCT00770887</DOCNO>
	<brief_summary>The purpose study assess continuation rate patient satisfaction self administration subcutaneous depot medroxyprogesterone acetate .</brief_summary>
	<brief_title>Self Administration Subcutaneous Depot Medroxyprogesterone Acetate</brief_title>
	<detailed_description>This observational study include new current Depo Provera user express interest attempt subcutaneous self administration depot medroxyprogesterone acetate . Candidates teach self administration clinic assistant Planned Parenthood Southwest Central Florida . Patients able correctly self administer medication wish attempt continue home self administration , provide supply educational material . Continuation rate satisfaction method assess use preaddressed survey patient return information .</detailed_description>
	<mesh_term>Medroxyprogesterone</mesh_term>
	<mesh_term>Medroxyprogesterone Acetate</mesh_term>
	<criteria>Women 18 year old Can understand write spoken English Current past user DMPA desire initiation DMPA contraception Provider approve DMPA use woman Willing consider/attempt DMPA selfinjection . Willing receive phone calls/letter follow Willing return letter follow Has contraindication DMPA use : Vaginal bleed unknown etiology Medication use Cushing 's syndrome Currently pregnant Blood pressure &gt; 160/100 Intolerance idea irregular absent menses</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Undesired fertility</keyword>
</DOC>